Stene LC et al. (2006) Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). Pediatr Diabetes 7: 247–253

Currently, there is no method to predict the onset of type 1 diabetes (T1D). Stene and colleagues investigated the efficacy of glycated hemoglobin (HbA1c) level (which can predict onset of type 2 diabetes) as a predictor of progression from islet autoimmunity to overt T1D.

The authors enrolled 92 children (mean age 4.8 years) who carried human leukocyte antigen genotypes associated with T1D or had first-degree relatives with T1D, and were positive for at least one islet autoantibody on at least two consecutive clinic visits. In total, 28 children developed T1D, at a median age of 6.5 years; 75% of these had first-degree relatives with the disease. Children who went on to develop T1D were slightly younger and had autoantibodies against a significantly higher number of islet antigens than children who did not (P = 0.008), although both groups had similar initial plasma glucose and HbA1c levels. Each increase of 1 SD (0.4%) in HbA1c levels was associated with a fivefold increase in the risk of progression to T1D. By contrast, each increase of 1 SD (1.1 mmol/l) in random plasma glucose levels resulted in only a slight (1.4-fold) increase in the risk of progression to T1D.

The authors conclude that rising HbA1c levels (even within the normal range) over time indicate progressive disruption of glucose regulation, and accurately predict the onset of T1D in high-risk children.